Literature DB >> 18634918

Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis.

Steven A Lubitz1, Seth H Goldbarg, Davendra Mehta.   

Abstract

Sarcoidosis, scleroderma, amyloidosis, and hemachromatosis are systemic infiltrative disorders that commonly affect the heart. Owing to their potential for diffuse organ involvement, these diseases may present with myriad clinical manifestations. Conduction system abnormalities are common, and each of these disorders has been associated with sudden cardiac death. In this review, we summarize the epidemiology, clinical features, diagnosis, and treatment of each of these entities. We place special emphasis on existing literature as it pertains to risk stratification and therapy aimed at the prevention of sudden cardiac death in these infiltrative cardiomyopathies.

Entities:  

Mesh:

Year:  2008        PMID: 18634918     DOI: 10.1016/j.pcad.2007.10.003

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  13 in total

1.  Implantable cardioverter defibrillator to prevent sudden cardiac death in a patient with systemic sclerosis: A clinical case.

Authors:  Fabio Marsico; Gianluigi Savarese; Celestino Sardu; Cristoforo D'Ascia; Donatella Ruggiero; Laura Casaretti; Valentina Parisi; Francesca Musella; Elisabetta Pirozzi; Roberto Formisano; Teresa Losco; Pasquale Perrone Filardi
Journal:  J Cardiol Cases       Date:  2012-03-31

Review 2.  Cardiac sarcoidosis.

Authors:  Matthew M Zipse; William H Sauer
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

Review 3.  Cardiac manifestations in systemic sclerosis.

Authors:  Sevdalina Lambova
Journal:  World J Cardiol       Date:  2014-09-26

Review 4.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

5.  HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011.

Authors:  Mark S Link; Derek V Exner; Mark Anderson; Michael Ackerman; Amin Al-Ahmad; Bradley P Knight; Steven M Markowitz; Elizabeth S Kaufman; David Haines; Samuel J Asirvatham; David J Callans; J Paul Mounsey; Frank Bogun; Sanjiv M Narayan; Andrew D Krahn; Suneet Mittal; Jagmeet Singh; John D Fisher; Sumeet S Chugh
Journal:  Heart Rhythm       Date:  2011-06-14       Impact factor: 6.343

Review 6.  Systemic sclerosis and the heart: current diagnosis and management.

Authors:  Chintan S Desai; Daniel C Lee; Sanjiv J Shah
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

Review 7.  Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases.

Authors:  Sophie I Mavrogeni; Petros P Sfikakis; Theodoros Dimitroulas; Loukia Koutsogeorgopoulou; George Markousis-Mavrogenis; George Poulos; Genovefa Kolovou; George Theodorakis; George D Kitas
Journal:  Rheumatol Int       Date:  2018-07-24       Impact factor: 2.631

Review 8.  Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.

Authors:  Steven E Lipshultz; Thomas R Cochran; David A Briston; Stefanie R Brown; Peter J Sambatakos; Tracie L Miller; Adriana A Carrillo; Liat Corcia; Janine E Sanchez; Melissa B Diamond; Michael Freundlich; Danielle Harake; Tamara Gayle; William G Harmon; Paolo G Rusconi; Satinder K Sandhu; James D Wilkinson
Journal:  Future Cardiol       Date:  2013-11

9.  Protective effect of geranylgeranylacetone via enhancement of HSPB8 induction in desmin-related cardiomyopathy.

Authors:  Atsushi Sanbe; Takuya Daicho; Reiko Mizutani; Toshiya Endo; Noriko Miyauchi; Junji Yamauchi; Kouichi Tanonaka; Charles Glabe; Akito Tanoue
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

10.  All that wheezes is not asthma.

Authors:  Andrew C Miller; Rashid M Rashid; Elamin M Elamin
Journal:  West J Emerg Med       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.